Author:
Fox Susan H.,Brotchie Jonathan M.,Johnston Tom M.
Reference171 articles.
1. Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys;Akai;J. Pharmacol. Exp. Ther.,1995
2. Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys;Alexander;Brain Res.,1992
3. A comparison of the behavioural effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions;Annett;Exp. Brain Res.,1995
4. Motor impairments and neurochemical changes after unilateral 6-hydroxydopamine lesion of the nigrostriatal dopaminergic system in monkeys;Apicella;Neuroscience,1990
5. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate;Aziz;Mov. Disord.,1991